DIAGNOS Announces Certification Advances for CARA System
DIAGNOS Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in the early detection of ophthalmic health issues using Artificial Intelligence (AI), has made significant progress in cybersecurity certification for its CARA System application. This advancement stems from thorough evaluations conducted by the Cyber Defense Operations Center (COCD).
Penetration Testing and Enhanced Security
As part of its commitment to achieving ISO 27001 certification, DIAGNOS has engaged in extensive penetration testing on the CARA System application, adhering to the strict cybersecurity requirements put forth by relevant health authorities. The tests revealed certain vulnerabilities, which DIAGNOS promptly addressed through rigorous regression testing completed in March 2025. This proactive approach allowed DIAGNOS to secure a favorable security assessment for CARA from COCD, affirming its compliance with the highest cybersecurity standards.
Integration into Healthcare Institutions
A formal notification regarding the successful integration of CARA into healthcare projects has been disseminated to healthcare institutions, including various healthcare centers. This approval allows these institutions to implement CARA as a tool within their operations, underscoring DIAGNOS’s commitment to enhancing healthcare outcomes through advanced technology.
CEO Remarks on Data Protection Commitment
André Larente, the CEO of DIAGNOS, emphasized the importance of protecting personal data. He stated that the completion of the cybersecurity intrusion test validated by Quebec's cybersecurity center exemplifies the robust security of the CARA application. This success not only highlights the company’s dedication to cybersecurity but also marks a crucial step toward obtaining ISO 27001 certification, with future audits slated to further confirm DIAGNOS’s commitment to security standards. Users can be fully assured of the company's stringent efforts to safeguard their information.
Progress on ISO 27001 Certification
In addition to cybersecurity measures, DIAGNOS is also making headway in its ISO 27001 certification journey. Specific audit dates have been arranged with the certification body Intertek, and updates regarding the process are anticipated to be released over the summer.
About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to the early detection of critical eye-related health issues. Utilizing the capabilities of Artificial Intelligence, DIAGNOS seeks to equip healthcare providers with more accurate diagnostic tools, enhancing efficiencies and improving patient outcomes globally.
Frequently Asked Questions
What is the CARA System?
The CARA System is an advanced application developed by DIAGNOS, utilizing Artificial Intelligence to aid in the early detection of ophthalmic health issues.
What does ISO 27001 certification indicate?
ISO 27001 certification demonstrates that an organization has implemented the best practices for information security management systems (ISMS), ensuring the protection of sensitive data.
How has DIAGNOS improved its cybersecurity?
DIAGNOS has conducted extensive penetration testing and promptly addressed identified vulnerabilities to enhance the security of the CARA application.
Who conducted the penetration tests for DIAGNOS?
The penetration tests were performed in accordance with recommendations from Quebec's Ministry of Health and were validated by the Cyber Defense Operations Center (COCD).
Where can I find more information about DIAGNOS?
More information about DIAGNOS and its offerings can be found on their official website at www.diagnos.com and on www.sedarplus.com.
